Psychological Treatment in Psychiatric Inpatient Care

Sponsor
Uppsala University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06012981
Collaborator
(none)
6
1
1
5
1.2

Study Details

Study Description

Brief Summary

This study aims to investigate the effect of a brief psychotherapeutic treatment intervention based on ACT, aimed specifically at the vulnerable group of patients in psychiatric 24-hour care treated according to LPT. The study aims to investigate whether a brief number of therapeutic sessions according to ACT during inpatient care produce positive effects on personally relevant life areas for a diagnostically mixed group of patients in a psychiatric intensive care unit.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
6 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single-case experimental design.Single-case experimental design.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Psychological Treatment in Psychiatric Inpatient Care
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jan 31, 2024
Anticipated Study Completion Date :
Jan 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acceptance & Commitment Therapy (ACT)

Psyhotherapy based on principles of functional analysis, behavioral activation, and experiential avoidance.

Behavioral: ACT
The treatment is based on a variant of CBT, as briefly referred to before, ACT. In short, the treatment consists of identifying central and important areas of life, and how to approach these even though you are also struggling with persistent and challenging problems. In this study, the treatment intervention is flexibly constructed, focusing on several central principles based on ACT. These can be applied during one or numerous sessions. The intervention is a flexible application of clinical functional analysis, as well as a couple of selected interventions which, in terms of experience and in previous studies, have been shown to work well for the current group (24-hour psychiatric patients with complex problems) and which are individually adaptable to the nature of the problem and degree.

Outcome Measures

Primary Outcome Measures

  1. Change in Personal Questionnaire [Four times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment session]

    Scores range from 1-4 per item (number of items might differ between patients as the measure is individually constructed. Higher scores correspond to worse outcome.

  2. Change in Bull's Eye Values Survey [Four times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment session]

    The score ranges from 0-28, higher scores corresponding to better outcome.

  3. Change in PHQ-9 [Four times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment session]

    The score ranges from 0-27, higher scores corresponding to worse outcome.

  4. Change in GAD-7 [Four times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment session]

    The score ranges from 0-21, higher scores corresponding to worse outcome.

  5. Change in Psy-flex [Four times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment session]

    The score ranges from 6-30, higher scores corresponding to better outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years old or older.

  • Treated according to the compulsory psychiatric care act.

  • Meet the criterion of informed consent.

Exclusion Criteria:
  • Lack the cognitive ability to acquire the treatment intervention, such as impaired attention, memory, logic and reasoning, and also auditory and visual processing. This will be based on a clinical assessment by the ward team, including the attending psychiatrist and a clinical psychologist.

  • Ongoing psychological treatment parallel to the admission.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital of Västmanland, Västerås Västerås Västmanland Sweden 72189

Sponsors and Collaborators

  • Uppsala University

Investigators

  • Study Director: Kent Nilsson, Professor, Uppsala University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marten Tyrberg, Principal Investigator, Uppsala University
ClinicalTrials.gov Identifier:
NCT06012981
Other Study ID Numbers:
  • 280468
First Posted:
Aug 28, 2023
Last Update Posted:
Aug 28, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 28, 2023